Value, Evidence, and Access: insights for markets outside of the EU5

These slides were presented in our on-demand webinar, Value, Evidence, and Access: insights for markets outside of the EU5”. 

Download the slides to find out about: 

  • health technology assessment and market access processes in several smaller EU markets: Bulgaria, the Czech Republic, Finland, the Netherlands, and Romania 

  • key considerations for manufacturers ahead of launch in these markets to drive operational excellence and secure timely, quality access 

  • how operational excellence and the PRMA Navigator® digital application can help maximize the likelihood of success in these markets.

FREE Slides

Fill in your details to download your FREE Slides

Latest insights

Driving BioPharma Access in Europe: Insights for ...

PRMA Consulting becomes Avalere Health, creating the ...

World Orphan Drug Congress 2023: solutions for market ...